{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Under Load","title":"My Prostate Report Wanted 25%. I Had 10%.","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/2adcda1f\"></iframe>","width":"100%","height":180,"duration":1025,"description":"On my way home from San Francisco, I checked my Function Health results. My PSA was 5.0, higher than the usual cut-off of 4. Only 10% of it was floating free in the blood, and the report wanted more than 25%. The clinician note called it \"a red flag.\" I'm a doctor, so I knew PSA can change for harmless reasons. I still made an appointment with a urologist.\nThis episode follows that result from the lab report to the MRI, and checks the numbers along the way. It starts with why men wait: the rectal exam many dread, and a pattern I call information loses to incentives. Your Tuesday meeting has a calendar invite. Your prostate doesn't. Germany's 2025 guideline says doctors should not use the finger exam for early detection, yet public insurance still pays for the finger exam from 45 and not for the PSA test.\nThen the evidence. The largest European trial invited men aged 55 to 69 to regular PSA tests and followed them for 23 years: one death from prostate cancer prevented for every 456 men invited, with 12 extra men diagnosed for each death prevented. A Swedish study found that men in the top tenth of PSA at age 45 to 49 accounted for 44% of later prostate cancer deaths. And in one American study, about 4 out of 10 men with a high PSA had a normal result at one or more later yearly checkups.\nThe 25% free-PSA cutoff comes from a 1998 study of men aged 50 to 75 with a PSA between 4 and 10, nearly half of whom had cancer. With 25% as the line, 95 out of 100 men with cancer fell below it, and so did about 80 out of 100 men whose biopsies were normal. My Berlin lab uses 15% for the same ratio.\nAlong the way: the strongest case against screening, from Germany's evidence institute IQWiG, and what a British trial showed when doctors watched instead of treating.\nThe episode closes with how I chose between an MRI and micro-ultrasound, what the one large trial of micro-ultrasound showed, what my MRI found, my verdicts, and three things you can do today.\nIn this episode:\nWhy men...","thumbnail_url":"https://img.transistorcdn.com/D6GUGKGhv_DEKkMXOUaw9zVKHR_WqCVlo9ECODchftY/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8wODc1/MzQxYzZmMTk4MDBl/ODhhM2E4NWIwYTFj/OWExOC5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}